[HTML][HTML] Quercetin for managing type 2 diabetes and its complications, an insight into multitarget therapy
R Dhanya - Biomedicine & Pharmacotherapy, 2022 - Elsevier
Background Quercetin, a bioflavonoid abundant in grapefruit, onion, berries, etc., has vast
therapeutic potential, especially against Type 2 diabetes and its complications. Quercetin …
therapeutic potential, especially against Type 2 diabetes and its complications. Quercetin …
Insulin receptor signaling in normal and insulin-resistant states
J Boucher, A Kleinridders… - Cold Spring Harbor …, 2014 - cshperspectives.cshlp.org
In the wake of the worldwide increase in type-2 diabetes, a major focus of research is
understanding the signaling pathways impacting this disease. Insulin signaling regulates …
understanding the signaling pathways impacting this disease. Insulin signaling regulates …
MicroRNAs as regulators of insulin signaling: research updates and potential therapeutic perspectives in type 2 diabetes
L Nigi, GE Grieco, G Ventriglia, N Brusco… - International journal of …, 2018 - mdpi.com
The insulin signaling pathway is composed of a large number of molecules that positively or
negatively modulate insulin specific signal transduction following its binding to the cognate …
negatively modulate insulin specific signal transduction following its binding to the cognate …
Hepatic exosome-derived miR-130a-3p attenuates glucose intolerance via suppressing PHLPP2 gene in adipocyte
J Wu, T Dong, T Chen, J Sun, J Luo, J He, L Wei… - Metabolism, 2020 - Elsevier
Objective Glucose and lipid metabolism disorders are a major risk factor for type II diabetes
and cardiovascular diseases. Evidence has indicated that the interplay between the liver …
and cardiovascular diseases. Evidence has indicated that the interplay between the liver …
Turning off AKT: PHLPP as a drug target
AC Newton, LC Trotman - Annual review of pharmacology and …, 2014 - annualreviews.org
Precise control of the balance between protein phosphorylation, catalyzed by protein
kinases, and protein dephosphorylation, catalyzed by protein phosphatases, is essential for …
kinases, and protein dephosphorylation, catalyzed by protein phosphatases, is essential for …
PHLPPing through history: a decade in the life of PHLPP phosphatases
AT Grzechnik, AC Newton - Biochemical Society Transactions, 2016 - portlandpress.com
In the decade since their discovery, the PH domain leucine-rich repeat protein
phosphatases (PHLPP) have emerged as critical regulators of cellular homeostasis, and …
phosphatases (PHLPP) have emerged as critical regulators of cellular homeostasis, and …
Circadian clock desynchronization and insulin resistance
F Catalano, F De Vito, V Cassano… - International Journal of …, 2022 - mdpi.com
The circadian rhythm regulates biological processes that occur within 24 h in living
organisms. It plays a fundamental role in maintaining biological functions and responds to …
organisms. It plays a fundamental role in maintaining biological functions and responds to …
The mammalian tribbles homolog TRIB3, glucose homeostasis, and cardiovascular diseases
Insulin signaling plays a physiological role in traditional insulin target tissues controlling
glucose homeostasis as well as in pancreatic β-cells and in the endothelium. Insulin …
glucose homeostasis as well as in pancreatic β-cells and in the endothelium. Insulin …
Suppression of survival signalling pathways by the phosphatase PHLPP
AK O'Neill, MJ Niederst, AC Newton - The FEBS journal, 2013 - Wiley Online Library
The recently discovered pleckstrin homology (PH) domain leucine‐rich repeat protein
phosphatase (PHLPP) family is emerging as a central component in suppressing cell …
phosphatase (PHLPP) family is emerging as a central component in suppressing cell …
Liver and insulin resistance: New wine in old bottle!!!
Hepatic and systemic insulin resistance form the core of metabolic syndrome which is also
associated with cardiovascular abnormalities, inflammation, and dyslipidemia. Skeletal …
associated with cardiovascular abnormalities, inflammation, and dyslipidemia. Skeletal …